Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing outcomes for freezing of gait in Parkinson's disease

Official title: An International Multimodal Protocol for Assessing Freezing of Gait in Individuals Living with Parkinson's Disease

Run by Tel-Aviv Sourasky Medical Center · NCT06519279 · Data updated 2026-11-12

This study is trying to find better ways to measure how bad freezing of gait is for people with Parkinson's disease who can walk on their own.

More Parkinson's Disease (PD) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorTel-Aviv Sourasky Medical Center
Government
Locations1 site (Tel Aviv)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedJanuary 28, 2025
Trial IDNCT06519279 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with idiopathic Parkinson's disease who experience freezing of gait and can walk independently.

Probably not a fit

Patients who have recently experienced significant cardiovascular events or have unstable medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop reliable clinician-reported and patient-reported outcome measures to quantify the severity of freezing of gait (FOG) in patients with Parkinson's disease. It will involve patients diagnosed with idiopathic Parkinson's disease who can walk independently and have stable treatment. The study will utilize specific interventions to gather data on FOG severity, which will help in creating standardized assessment tools for clinicians and researchers.

Why it matters

Potential benefit: If successful, this study could provide a standardized method for assessing freezing of gait, leading to improved management and treatment strategies for patients with Parkinson's disease.

How similar studies have gone: Other studies have shown success in developing outcome measures for Parkinson's disease, indicating that this approach has potential for meaningful advancements.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of idiopathic Parkinson's disease (PD) made by a neurologist according to the Movement Disorders Society guidelines;
2. Able to walk independently for a distance of 10 meters, without walking aid;
3. Absence of a Deep Brain Stimulator;
4. Stable PD treatment in the 4 weeks prior to participation that is not expected to change in the course of the study.
5. For patients with FOG: a score of ≥ 1 on the New Freezing Of Gait Questionnaire (NFOG-Q).

Exclusion Criteria:

1. Occurrence of any of the following within 3 months prior to informed consent: myocardial infarction, hospitalization for unstable angina, stroke, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), implantation of a cardiac resynchronization therapy device (CRTD), active treatment for cancer or other malignant disease, uncontrolled congestive heart disease (NYHA class \>3), acute psychosis or major psychiatric disorders or continued substance abuse, other neurological (than PD) or orthopaedic impairment that significantly impacts on gait.
2. Unwilling to temporarily delay the morning anti-Parkinsonian medication.
3. Preganacy and

Where it's running

  • Tel Aviv Saurasky Medical Center
    Tel Aviv, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.